These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8383387)

  • 1. Preparation and immunogenicity of an inactivated hepatitis A vaccine.
    Pellegrini V; Fineschi N; Matteucci G; Marsili I; Nencioni L; Puddu M; Garelick H; Zuckerman AJ
    Vaccine; 1993; 11(3):383-7. PubMed ID: 8383387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity of a hepatitis A virus vaccine.
    Flehmig B; Haage A; Pfisterer M
    J Med Virol; 1987 May; 22(1):7-16. PubMed ID: 3035082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A.
    Delem A; Safary A; De Namur F; Hauser P; D'Hondt E
    Vaccine; 1993; 11(4):479-84. PubMed ID: 8385844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An inactivated hepatitis A viral vaccine of cell culture origin.
    Provost PJ; Hughes JV; Miller WJ; Giesa PA; Banker FS; Emini EA
    J Med Virol; 1986 May; 19(1):23-31. PubMed ID: 3009703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the antibody response in humans with a new inactivated hepatitis A vaccine.
    Vidor E; Xueref C; Blondeau C; Bajard A; Francon A; Goudeau A; Peyron F; Brasseur P; Zuckerman A
    Biologicals; 1996 Sep; 24(3):235-42. PubMed ID: 8978923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a prototype inactivated hepatitis A virus vaccine from infected cell cultures.
    Binn LN; Bancroft WH; Lemon SM; Marchwicki RH; LeDuc JW; Trahan CJ; Staley EC; Keenan CM
    J Infect Dis; 1986 Apr; 153(4):749-56. PubMed ID: 3005435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of virus strain and antigen dose on immunogenicity and reactogenicity of an inactivated hepatitis A vaccine.
    Goubau P; Van Gerven V; Safary A; Delem A; Knops J; D'Hondt E; André FE; Desmyter J
    Vaccine; 1992; 10 Suppl 1():S114-8. PubMed ID: 1335638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
    Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
    Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules.
    Troisi CL; Hollinger FB; Krause DS; Pickering LK
    Vaccine; 1997 Oct; 15(15):1613-7. PubMed ID: 9364691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and booster dose responses to an inactivated hepatitis A virus vaccine: comparison with immune serum globulin prophylaxis.
    Shouval D; Ashur Y; Adler R; Lewis JA; Armstrong ME; Davide JP; McGuire B; Kuter B; Brown L; Miller W
    Vaccine; 1993; 11 Suppl 1():S9-14. PubMed ID: 8383390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production, quality control and characterization of an inactivated hepatitis A vaccine.
    Peetermans J
    Vaccine; 1992; 10 Suppl 1():S99-101. PubMed ID: 1335671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental in vivo passage of H2 strain of live attenuated vaccine of hepatitis A in common marmosets].
    Huang X; Lian Y; Wang Q
    Zhonghua Yu Fang Yi Xue Za Zhi; 1997 Sep; 31(5):260-2. PubMed ID: 9812599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactogenicity and immunogenicity of inactivated hepatitis A vaccines.
    Just M; Berger R
    Vaccine; 1992; 10 Suppl 1():S110-3. PubMed ID: 1362031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of a killed hepatitis A vaccine in seronegative volunteers.
    Flehmig B; Heinricy U; Pfisterer M
    Lancet; 1989 May; 1(8646):1039-41. PubMed ID: 2565998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals.
    Davidson M; Krugman S; Sandman LA
    Vaccine; 1992; 10 Suppl 1():S119-20. PubMed ID: 1335639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic approaches to assessing the response to inactivated hepatitis A vaccine.
    Lemon SM
    J Hepatol; 1993; 18 Suppl 2():S15-9. PubMed ID: 8182266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers.
    Wiedermann G; Ambrosch F; Kollaritsch H; Hofmann H; Kunz C; D'Hondt E; Delem A; André FE; Safary A; Stéphenne J
    Vaccine; 1990 Dec; 8(6):581-4. PubMed ID: 1965077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
    Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A redoubtable obstacle to a hepatitis C vaccine.
    Koff RS
    Gastroenterology; 1993 Apr; 104(4):1228-9. PubMed ID: 8385045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.